对重组激活因子VII在严重产后出血中潜在使用的推理
Nándor Ács1, Wolfgang C Korte2, Christian C von Heymann3
1Department of Obstetrics and Gynaecology, Semmelweis University, H-1082 Budapest, Hungary.
Journal of clinical medicine
|May 25, 2024
概括
重组激活因子VII (rFVIIa) 通过促进局部血栓生成,有效控制产后严重出血 (PPH). 安全数据令人放心,支持其与PPH标准治疗一起使用.
科学领域:
- 产科和妇科 产科和妇科
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 产后严重出血 (PPH) 是全球主要的孕产妇死亡原因.
- 重组激活因子VII (rFVIIa) 已被批准用于严重的PPH,当子宫激素失败时.
- 在PPH中rFVIIa的机制尚未完全理解,因为它不能取代缺失的因素.
研究的目的:
- 讨论 rFVIIa 在严重PPH中有效性的潜在机制.
- 审查已发表的证据支持rFVIIa在此背景下使用.
- 为了解决有关血栓栓塞事件的安全问题.
主要方法:
- 从较小的研究和国际注册表中收集到的证据的审查.
- 对rFVIIa的作用提出的机制性解释的讨论.
- 对严重PPH患者发表的安全数据的分析.
主要成果:
- rFVIIa可能通过与激活的血小板结合,在血管损伤部位增强局部血小板生成.
- 这种局部作用可能解释了有效性,而没有显著的全身前凝效应.
- 现有的安全数据表明,在接受rFVIIa治疗的PPH妇女中,血栓栓塞事件的发生率没有增加.
结论:
- rFVIIa是严重PPH标准治疗的有效补充剂.
- 在显著的稀释凝血病发生之前,请考虑rFVIIa的使用.
- 在PPH中,rFVIIa的安全概况似乎是有利的.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
681
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
681
Introduction to Hemostasis
7.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.3K
Extrinsic and Intrinsic Pathways of Hemostasis
7.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.2K
Clot Retraction and Fibrinolysis
5.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.5K


